Modulation of Remifentanil-Induced Analgesia and Postinfusion Hyperalgesia by Parecoxib or Ketorolac in Humans.

Trial Profile

Modulation of Remifentanil-Induced Analgesia and Postinfusion Hyperalgesia by Parecoxib or Ketorolac in Humans.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2011

At a glance

  • Drugs Ketorolac (Primary) ; Parecoxib (Primary) ; Remifentanil
  • Indications Hyperalgesia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Sep 2010 Results were presented at the 13th World Congress on Pain.
    • 05 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top